Early Ultrasound Surveillance of Newly-Created Hemodialysis Arteriovenous Fistula.

Doppler ultrasonography arteriovenous fistula hemodialysis surveillance vascular access surgery

Journal

Kidney international reports
ISSN: 2468-0249
Titre abrégé: Kidney Int Rep
Pays: United States
ID NLM: 101684752

Informations de publication

Date de publication:
Apr 2024
Historique:
received: 26 09 2023
revised: 28 12 2023
accepted: 02 01 2024
medline: 20 5 2024
pubmed: 20 5 2024
entrez: 20 5 2024
Statut: epublish

Résumé

We assess if ultrasound surveillance of newly-created arteriovenous fistulas (AVFs) can predict nonmaturation sufficiently reliably to justify randomized controlled trial (RCT) evaluation of ultrasound-directed salvage intervention. Consenting adults underwent blinded fortnightly ultrasound scanning of their AVF after creation, with scan characteristics that predicted AVF nonmaturation identified by logistic regression modeling. Of 333 AVFs created, 65.8% matured by 10 weeks. Serial scanning revealed that maturation occurred rapidly, whereas consistently lower fistula flow rates and venous diameters were observed in those that did not mature. Wrist and elbow AVF nonmaturation could be optimally modeled from week 4 ultrasound parameters alone, but with only moderate positive predictive values (PPVs) (wrist, 60.6% [95% confidence interval, CI: 43.9-77.3]; elbow, 66.7% [48.9-84.4]). Moreover, 40 (70.2%) of the 57 AVFs that thrombosed by week 10 had already failed by the week 4 scan, thus limiting the potential of salvage procedures initiated by that scan's findings to alter overall maturation rates. Modeling of the early ultrasound characteristics could also predict primary patency failure at 6 months; however, that model performed poorly at predicting assisted primary failure (those AVFs that failed despite a salvage attempt), partly because patency of at-risk AVFs was maintained by successful salvage performed without recourse to the early scan data. Early ultrasound surveillance may predict fistula maturation, but is likely, at best, to result in only very modest improvements in fistula patency. Power calculations suggest that an impractically large number of participants (>1700) would be required for formal RCT evaluation.

Identifiants

pubmed: 38765580
doi: 10.1016/j.ekir.2024.01.011
pii: S2468-0249(24)00011-1
pmc: PMC11101727
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1005-1019

Investigateurs

Anna Sidders (A)
Cara Hudson (C)
Claire Foley (C)
Valerie Hopkins (V)
Emma Laing (E)
Chloe Fitzpatrick-Creamer (C)
Helen Thomas (H)
Alison Deary (A)
Gavin J Pettigrew (GJ)
James Richards (J)
Mohammed Hossain (M)
Dominic Summers (D)
Matthew Slater (M)
Laura Scott (L)
Regin Lagaac (R)
Veena Surendrakumar (V)
Tobi Ayorinde (T)
Igor Chipurovski (I)
Manikandan Kathirvel (M)
Manoj Thialli (M)
Subhankar Paul (S)
Andrew Norton (A)
Simon Knight (S)
Klaus Bond (K)
Elizabeth Hardy (E)
Joanne Widdup (J)
Rachael Potter (R)
Elisabeth Pugh (E)
Karen Parsons (K)
Kathryn Lafferty (K)
Madita Gavrila (M)
Sheera Sutherland (S)
Ria Rabara (R)
Rajesh Sivaprakasam (R)
Kate Crawford (K)
Amy Bolsworth (A)
Naavalah Ngwa-Ndifor (N)
Laura Clementoni (L)
Reza Motallebzadeh (R)
Mohammad Ayaz Hossain (MA)
Matthew Bartlett (M)
Rani Badhan (R)
Fernando Yuenchang (F)
Phil Gardiner (P)
Natasha Irani (N)
Zia Moinuddin (Z)
Helena Edlin (H)
Anna Jerram (A)
Jessica Lai (J)
Joyce Banda (J)
Janet Bendle (J)
Sam Turner (S)
Maria Morgan (M)
William Owen (W)
Sue Dawson (S)
Simon Daniel (S)
Karen Allsop (K)
Andrew Tambyraja (A)
Sarah-Jane Carmichael (SJ)
Tom Eadie (T)
Rona Lochiel (R)
Midel Lena (M)
Karen Gallagher (K)
Nicholas Barnett (N)
Soundrie Padayachee (S)
Philip Eldridge (P)
May Rabuya (M)
Naomi Hare (N)
Subash Somalanka (S)
Jashree Patel (J)
Abbas Ghazanfar (A)
Judy van Selm (J)
Caroline Bodneck (C)
Martia Augustin (M)
Kwame Ansu (K)
Nalin Khosla (N)
Kashif Burney (K)
Karen Dear (K)
Duminda Basnayake (D)
Laijee Benny (L)
James Hunter (J)
Carl Tiivas (C)
Samantha Hyndman (S)
Maria Truslove (M)
Gail Evans (G)
Kerry Read (K)
Sam Dutta (S)
Andrew Beech (A)
Sarah Brand (S)
Tara MacCormick-Swanson (T)
Sarah Lawman (S)
Darren Cheal (D)
Mel Smith (M)
Kate Trivedi (K)
Valentina Toska (V)
Lorraine Shah-Goodwin (L)
Tracey Salter (T)
Adnan Bajwa (A)
John Kerr (J)
Ana Fleet (A)
Lianne Chapman (L)
Sarah Gee (S)
Thanuja Weerasinghe (T)
Lisa Kavanagh (L)
Louise Rowe-Leete (L)
George Smith (G)
Paris Cai (P)
Judith Long (J)
Tracey Rowe (T)
Mohammed Aslam (M)
Jeremy Crane (J)
Atul Bagul (A)
Mary Quashie-Akponeware (M)
Kate Waters (K)
Alexandra Howson (A)
Neil Hoye (N)
Alycon Walker (A)

Informations de copyright

© 2024 Published by Elsevier, Inc., on behalf of the International Society of Nephrology.

Auteurs

James Richards (J)

Addenbrooke's Hospital, Hill Road, Cambridge, UK.
University of Cambridge, Hill Road, Cambridge, UK.
Royal Free London NHS Foundation Trust, London, UK.

Dominic Summers (D)

Addenbrooke's Hospital, Hill Road, Cambridge, UK.
University of Cambridge, Hill Road, Cambridge, UK.

Anna Sidders (A)

NHS Blood and Transplant Clinical Trials Unit, Cambridge, UK.

Elisa Allen (E)

NHS Blood and Transplant Clinical Trials Unit, Cambridge, UK.

Helen Thomas (H)

NHS Blood and Transplant Clinical Trials Unit, Cambridge, UK.

Mohammed Ayaz Hossain (MA)

Royal Free London NHS Foundation Trust, London, UK.

Subhankar Paul (S)

Addenbrooke's Hospital, Hill Road, Cambridge, UK.
University of Cambridge, Hill Road, Cambridge, UK.

Matthew Slater (M)

Addenbrooke's Hospital, Hill Road, Cambridge, UK.

Matthew Bartlett (M)

Royal Free London NHS Foundation Trust, London, UK.

Regin Lagaac (R)

Addenbrooke's Hospital, Hill Road, Cambridge, UK.

Emma Laing (E)

NHS Blood and Transplant Clinical Trials Unit, Cambridge, UK.

Valerie Hopkins (V)

NHS Blood and Transplant Clinical Trials Unit, Cambridge, UK.

Chloe Fitzpatrick-Creamer (C)

NHS Blood and Transplant Clinical Trials Unit, Cambridge, UK.

Cara Hudson (C)

NHS Blood and Transplant Clinical Trials Unit, Cambridge, UK.

Joseph Parsons (J)

NHS Blood and Transplant Clinical Trials Unit, Cambridge, UK.

Sam Turner (S)

North Bristol NHS Trust, Bristol, UK.

Andrew Tambyraja (A)

Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK.

Subash Somalanka (S)

Epsom and St Helier University Hospitals NHS Trust, Carshalton, UK.

James Hunter (J)

University Hospital Coventry and Warwickshire NHS Trust, Coventry, UK.

Sam Dutta (S)

Nottingham University Hospitals NHS Trust, Nottingham, UK.

Neil Hoye (N)

South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK.

Sarah Lawman (S)

Brighton and Sussex University Hospitals NHS Trust, Worthing, West Sussex, UK.

Tracey Salter (T)

Epsom and St Helier University Hospitals NHS Trust, Carshalton, UK.
Frimley Health NHS Foundation Trust, Camberley, Surrey, UK.

Mohammed Aslam (M)

Imperial College Healthcare NHS Trust, London, UK.

Atul Bagul (A)

University Hospitals of Leicester NHS Trust, Leicester, UK.

Rajesh Sivaprakasam (R)

Bart's Health NHS Trust, London, UK.

George Smith (G)

Hull University Teaching Hospitals NHS Trust, Hull, UK.

Zia Moinuddin (Z)

Manchester University NHS Foundation Trust, Manchester, UK.

Simon Knight (S)

Oxford University Hospitals NHS Foundation Trust, Headington Oxford, UK.

Nicholas Barnett (N)

Guy's and St Thomas' NHS Foundation Trust, London, UK.

Reza Motallebzadeh (R)

Royal Free London NHS Foundation Trust, London, UK.

Gavin J Pettigrew (GJ)

Addenbrooke's Hospital, Hill Road, Cambridge, UK.
University of Cambridge, Hill Road, Cambridge, UK.

Classifications MeSH